| Execution period | 3 years |
|---|
NSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹938.75
- Market cap
- ₹14,953 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 42.5×Sector 41.3×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Board Meeting Date
Jubilant Pharmova has scheduled a board meeting for November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a Regulation 29 advance intimation only.
Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received a credit rating of IND AA+/Stable from India Ratings and Research for its proposed Non-Convertible Debentures worth ₹1,400 Crore.
- Value
- ₹1,400 Cr
Jubilant Pharmova Other Announcement
Jubilant Pharmova Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received an [ICRA]AA+ (Stable) rating from ICRA for its proposed non-convertible debentures. This confirms the credit assessment for the upcoming debt instrument.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova board approved NCD issuance up to ₹800 crore on private placement basis. Postal ballot also sought for NCD authorization up to ₹2,500 crore.
- Value
- ₹800.0 Cr
- Execution
- Upto five years from the Deemed Date of Allotment
Other board meeting outcome announcements
All →Kasturi Metal Composite Board Meeting Outcome
Kasturi Metal Composite's board approved voluntarily publishing quarterly financial results from the quarter ending December 31, 2026. The mandatory SME filings remain half-yearly.
Tanvi Foods (India) Board Meeting Outcome
Tanvi Foods (India) Limited re-appointed Ms. Jonnada Vaghira Kumari as Non-Executive Independent Director for 60 months, effective 3 November 2026. This is a routine board-level director re-appointment.
Jyoti Structures Board Meeting Outcome
Jyoti Structures reconstituted its Nomination and Remuneration Committee and Risk Management Committee after its November 3, 2026 board meeting. The filing lists the revised members and chairpersons only.
Dhampure Specialty Sugars Board Meeting Outcome
Dhampure Speciality Sugars reconstituted its Audit, Nomination & Remuneration and Stakeholders' Relationship Committees effective 3 Nov 2026. No money or business event is involved.
Hardwyn India Board Meeting Outcome
Hardwyn India appointed M/s. Amit H.V. & Associates as the new Secretarial Auditor to fill a casual vacancy for the financial year 2025-2026.
The Orissa Minerals Development Company Board Meeting Outcome
Orissa Minerals Development Company's board approved the Directors' Report and notice for its 108th AGM on 3 November 2026. The filing also notes other agenda items, but none are specified.